Brain, Vol. 124, No. 1, 5-19,
January 2001
© 2001 Oxford University Press
Review Article |
The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma
1 Service of Neurosurgery, Hospital de Navarra and 2 Movement Disorders and Basal Ganglia Unit, Department of Neurology and Neurosurgery, Neuroscience Program, Clinica Universitaria and Medical School, Universidad de Navarra, 31008 Pamplona, Spain
Correspondence to:
Dr J. A. Obeso, Clínica Universitaria, Apartado 4209, 31080 Pamplona, Spain E-mail: jobeso{at}unav.es
The subthalamic nucleus (STN) currently is considered to play a key role in the pathophysiological origin of the parkinsonian state and is therefore the main target for surgical treatment of Parkinson's disease. The authors review the incidence of hemichorea/ballism (HCB) as a complication of thalamotomy, pallidotomy or campotomy procedures before the introduction of levodopa therapy, including the few reported cases accompanied by a neuropathological study. The literature shows that only a small number of parkinsonian patients with HCB had a lesion of the STN. Preliminary data in Parkinson's disease patients submitted to a subthalamotomy with current functional stereotaxy also indicate that HCB is a very rare complication. To explain this observation, we suggest that the parkinsonian state is characterized by an increased threshold for the induction of dyskinesia following STN lesioning. This arises as a consequence of reduced activity in the `direct' GABA projection to the globus pallidus medialis (GPm) which accompanies dopamine depletion. Lesioning of the STN reduces excitation of the GPm, and theoretically this should induce dyskinesias. However, an STN lesion also, simultaneously, further reduces the hypoactivity in the globus pallidus lateralis (GPl) that is a feature of Parkinson's disease, and hence may compensate for GPm hypoactivity, thus self-stabilizing basal ganglia output activity and reducing the risk of HCB. We conclude that lesioning of the STN in Parkinson's disease is a feasible approach in some circumstances.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Boulet, E. Lacombe, C. Carcenac, C. Feuerstein, V. Sgambato-Faure, A. Poupard, and M. Savasta Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata. J. Neurosci., October 18, 2006; 26(42): 10768 - 10776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Merello, S Perez-Lloret, J Antico, and J A Obeso Dyskinesias induced by subthalamotomy in Parkinson's disease are unresponsive to amantadine J. Neurol. Neurosurg. Psychiatry, February 1, 2006; 77(2): 172 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Windels, C. Carcenac, A. Poupard, and M. Savasta Pallidal Origin of GABA Release within the Substantia Nigra Pars Reticulata during High-Frequency Stimulation of the Subthalamic Nucleus J. Neurosci., May 18, 2005; 25(20): 5079 - 5086. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Alvarez, R. Macias, G. Lopez, E. Alvarez, N. Pavon, M. C. Rodriguez-Oroz, J. L. Juncos, C. Maragoto, J. Guridi, I. Litvan, et al. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response Brain, March 1, 2005; 128(3): 570 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hamani, J. A. Saint-Cyr, J. Fraser, M. Kaplitt, and A. M. Lozano The subthalamic nucleus in the context of movement disorders Brain, January 1, 2004; 127(1): 4 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Paradiso, J. A. Saint-Cyr, A. M. Lozano, A. E. Lang, and R. Chen Involvement of the human subthalamic nucleus in movement preparation Neurology, December 9, 2003; 61(11): 1538 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schroeder, A. Kuehler, B. Haslinger, P. Erhard, W. Fogel, V. M. Tronnier, K. W. Lange, H. Boecker, and A. O. Ceballos-Baumann Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study Brain, September 1, 2002; 125(9): 1995 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Salin, C. Manrique, C. Forni, and L. K.-L. Goff High-Frequency Stimulation of the Subthalamic Nucleus Selectively Reverses Dopamine Denervation-Induced Cellular Defects in the Output Structures of the Basal Ganglia in the Rat J. Neurosci., June 15, 2002; 22(12): 5137 - 5148. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gregory SURGERY FOR MOVEMENT DISORDERS J. Neurol. Neurosurg. Psychiatry, March 1, 2002; 72(90001): i32 - 35. [Full Text] [PDF] |
||||
![]() |
M. S. Baron, T. Wichmann, D. Ma, and M. R. DeLong Effects of Transient Focal Inactivation of the Basal Ganglia in Parkinsonian Primates J. Neurosci., January 15, 2002; 22(2): 592 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Eskandar, G. R. Cosgrove, and L. A. Shinobu Surgical Treatment of Parkinson Disease JAMA, December 26, 2001; 286(24): 3056 - 3059. [Full Text] [PDF] |
||||




